Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 7Sanofi
02 7Amgen Inc
03 2Apotex Inc
04 2BIOSIMILAR COLLABORATIONS IRELAND LIMITED
05 40Bayer AG
06 1Biosimilar Collaborations Ireland Limited
07 2Celltrion
08 3Formycon
09 1ORIFARM GROUP AS
10 2Regeneron Pharmaceuticals
11 2Samsung Bioepis
12 5Sandoz B2B
01 3Concentrate For Infusion Solution
02 2Concentrate For Solution For Infusion
03 1Concentrate For Solution For Perfusion
04 1INJ
05 2INJECTABLE; INJECTION
06 5INJECTABLE;INJECTION
07 10Injectable Solution
08 4Injectable Solution In Pre-Filled Syringe
09 3Injectable Solution In Vial
10 8SOLUTION
11 11Solution For Injection
12 4Solution for injection
13 20Blank
01 8Allowed
02 15Approved
03 11Authorized
04 1Originator
05 6Prescription
06 2Schedule D
07 31Blank
01 2AFLIVU
02 1AHZANTIVE
03 4Afqlir
04 1Ahzantive
05 1Baiama
06 1ENZEEVU
07 3EYLEA
08 3EYLEA HD
09 2Eydenzelt
10 34Eylea
11 3Eylea
12 1OPUVIZ
13 1Opuviz
14 1PAVBLU
15 4Pavblu
16 2Peacock Blue
17 2YESAFILI
18 1Yesafili
19 1ZALTRAP
20 6Zaltrap
01 20Australia
02 8Canada
03 4Norway
04 1South Africa
05 11Spain
06 15Sweden
07 8Switzerland
08 7USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : ZALTRAP
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 125418
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Zaltrap
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 25mg/ml
Packaging :
Approval Date : 2013-02-01
Application Number : 20111126000035
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Zaltrap
Dosage Form : Concentrate For Solution For Perfusion
Dosage Strength : 100mg/4ml
Packaging :
Approval Date : 2013-03-20
Application Number : 62676
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Zaltrap
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 200mg/8ml
Packaging :
Approval Date : 2013-03-20
Application Number : 62676
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Zaltrap
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 25MG
Packaging :
Approval Date : 2013-02-22
Application Number : 112814002
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Zaltrap
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 25MG
Packaging :
Approval Date : 2013-02-22
Application Number : 112814001
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Zaltrap
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 25MG
Packaging :
Approval Date : 2013-02-22
Application Number : 112814003
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info :
Registration Country : USA
Brand Name : PAVBLU
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2 mg (0.05 mL of 40 mg/mL)
Packaging :
Approval Date :
Application Number : 761298
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Eylea
Dosage Form : Solution for injection
Dosage Strength : 114.3 mg/ml
Packaging : Vials 1 0.263ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Eylea
Dosage Form : Solution for injection
Dosage Strength : 40 mg/ml
Packaging : Vials 0.1ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Eylea
Dosage Form : Solution for injection
Dosage Strength : 40 mg/ml
Packaging : Pre-filled syringe 0.09ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Brand Name : AHZANTIVE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG(0.05ML OF 40MG/ML)
Packaging :
Approval Date :
Application Number : 761378
Regulatory Info :
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Ahzantive
Dosage Form : Injectable Solution
Dosage Strength : 40mg/ml
Packaging :
Approval Date : 2025-01-13
Application Number : 20240426000091
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Eylea
Dosage Form : Solution for injection
Dosage Strength : 40 mg/ml
Packaging : Vials 0.1ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Brand Name : EYLEA
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 40MG/ML
Packaging :
Approval Date :
Application Number : 125387
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : EYLEA HD
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 8MG(0.07ML;114.3MG/ML)
Packaging :
Approval Date :
Application Number : 761355
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : OPUVIZ
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG(0.05ML,40MG/ML)
Packaging :
Approval Date :
Application Number : 761350
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ENZEEVU
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG(0.05ML of 40MG/ML)
Packaging :
Approval Date :
Application Number : 761382
Regulatory Info :
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Afqlir
Dosage Form : Injectable Solution
Dosage Strength : 40mg/ml
Packaging :
Approval Date : 2024-11-13
Application Number : 20230823000046
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Afqlir
Dosage Form : Solution For Injection
Dosage Strength : 40mg/ml
Packaging :
Approval Date : 2024-11-13
Application Number : 20230823000039
Regulatory Info : Approved
Registration Country : Sweden
